ctrl K

Price Alert

Aerpio Pharmaceuticals In... (ARPO)

NASDAQ: ARPO · Real-Time Price · USD

2.20

-0.02 (-0.90%)

At close: Aug 27, 2021, 6:00 AM

Aerpio Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024
Product Revenue	25.98M
Product Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Selling, General, and Administrative Revenue	5.94M	12.81M	28.28M	7.19M	7.89M	3.58M	2.35M	2.54M	1.81M	1.56M	2.08M	1.98M	2.22M	1.77M	2.14M	2.15M	1.98M	1.84M	1.97M	2.17M	3.54M	3.76M	1.58M	780K	2.21M	514K	557K	639K
Selling, General, and Administrative Revenue Growth	-53.65%	-54.68%	+293.52%	-8.95%	+120.26%	+52.47%	-7.41%	+40.22%	+15.95%	-25.06%	+5.04%	-10.80%	+25.74%	-17.34%	-0.56%	+8.80%	+7.15%	-6.49%	-9.12%	-38.76%	-5.67%	+137.55%	+102.82%	-64.71%	+329.96%	-7.72%	-12.83%	n/a
Research and Development Revenue	48.81M	8.79M	25.19M	10M	13.09M	7.98M	8.26M	9.6M	9.57M	8.4M	9.02M	8.03M	4.81M	5.63M	5.22M	4.35M	4.98M	4.07M	2.65M	2.75M	1.67M	3.02M	3.08M	2.06M	1.98M	1.92M	2.29M	8.95M
Research and Development Revenue Growth	+455.41%	-65.11%	+151.97%	-23.65%	+64.11%	-3.40%	-14.00%	+0.37%	+13.92%	-6.87%	+12.36%	+66.76%	-14.43%	+7.67%	+20.11%	-12.65%	+22.48%	+53.55%	-3.71%	+64.87%	-44.75%	-1.85%	+49.25%	+3.88%	+3.60%	-16.23%	-74.47%	n/a